Friday, June 10, 2022

News From #ASCO22 Part 3, Addressing Challenges in Ovarian Cancer

Repeating PARP maintenance in ovarian cancer recurrence may have only a small benefit.




Challenges in OC #ASCO22 #gyncsm
Van Driel - HIPEC: Is It Ready for Prime Time in Ovarian Cancer?
Multidisciplinary team and surgical skills needed to use HIPEC.

Use Hipec in combo with Cytoreductive surgery.


Check back on Monday for my take on the Gyn Cancer Poster Discussion session.

Every Day is a Blessing!

No comments: